Further data pertaining to other countries would be interesting to uncover whether ethnic differences also affect cartilage thickness. Collaborative use of MSUS seems to be promising in this regard.

No abstract

Objective: Neuropathic pain is a frequent complication of spinal cord injury. Almost 70% of patients with spinal cord injury (SCI) experience pain, and nearly one-third of these patients describe their pain as severe. Gabapentin and pregabalin are considered as first-line treatment for post-SCI neuropathic pain. However, there is no study comparing the effects of gabapentin and pregabalin in the management of neuropathic pain in patients with SCI. In this prospective, randomized, crossover clinical trial, we aimed to compare the efficacy of gabapentin and pregabalin in the treatment of neuropathic pain associated with SCI. Material and Methods: Thirty patients with spinal cord injury experiencing neuropathic pain were recruited for the study. Patients took medications for 8 weeks. After a 2-week washout period, medications were switched in a crossover design. The outcome measures for this study were visual analogue scale (VAS) for pain, VAS for sleep, Short Form Beck Depression Inventory, and the pain disability index. Results: Twenty-one patients completed the study. Seven patients who did not want to change their medication while they were using the first drug (4 patients were using gabapentin and 3 patients were using pregabalin) and 2 patients who experienced dizziness and nausea (both were in the pregabalin group) were dropped off. There was no difference between both drugs in terms of their efficacy for pain, anxiety, and sleep (p<0.05). Conclusion: There was no statistically significant difference between gabapentin and pregabalin in terms of study parameters for the treatment of neuropathic pain in patients with SCI.

No abstract

Background/Objective: To present a case of autonomic dysreflexia caused by the use of a fecal management system in a patient with tetraplegia. Design: Case report. Setting: Military rehabilitation center. Results: A man with tetraplegia had a fecal management system inserted to divert stool away from his sacral pressure ulcer to reduce contamination and infection risk. Two days later, he developed severe autonomic dysreflexia that improved after removal of the system. Conclusions: Autonomic dysreflexia, a life-threatening complication, has not been reported before as a side effect of a fecal management system. These systems should be used with caution in patients with highlevel spinal cord injury.

Clinicians should keep in mind that heterotopic ossification can occur in non-hemiplegic extremities as well as hemiplegic extremities in patients with TBI in whom the extent of neurologic damage cannot be definitely established.

No abstract

Letters to the Editor should be submitted online to www.editorialmanager.com/ amsurg. (See details online under ''Instructions for Authors''.) They should be no more than 3 double-spaced pages excluding an Abstract and sub-headings with a maximum of four (4) references. If figures are included, they should be limited to two (2). The cost of printing color figures is the responsibility of the author.